- Home
- CBAN vs DMAC Comparison
CBAN vs DMAC Comparison
Compare CBAN & DMAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CBAN
- DMAC
- Stock Information
- Founded
- CBAN 1975
- DMAC 2000
- Country
- CBAN United States
- DMAC United States
- Employees
- CBAN N/A
- DMAC N/A
- Industry
- CBAN Major Banks
- DMAC Biotechnology: Pharmaceutical Preparations
- Sector
- CBAN Finance
- DMAC Health Care
- Exchange
- CBAN Nasdaq
- DMAC Nasdaq
- Market Cap
- CBAN 295.6M
- DMAC 267.7M
- IPO Year
- CBAN 1998
- DMAC N/A
- Fundamental
- Price
- CBAN $15.98
- DMAC $5.77
- Analyst Decision
- CBAN
- DMAC Strong Buy
- Analyst Count
- CBAN 0
- DMAC 3
- Target Price
- CBAN N/A
- DMAC $7.00
- AVG Volume (30 Days)
- CBAN 78.4K
- DMAC 92.0K
- Earning Date
- CBAN 04-23-2025
- DMAC 05-07-2025
- Dividend Yield
- CBAN 2.88%
- DMAC N/A
- EPS Growth
- CBAN 9.88
- DMAC N/A
- EPS
- CBAN 1.36
- DMAC N/A
- Revenue
- CBAN $112,401,000.00
- DMAC N/A
- Revenue This Year
- CBAN $14.25
- DMAC N/A
- Revenue Next Year
- CBAN $6.28
- DMAC N/A
- P/E Ratio
- CBAN $11.76
- DMAC N/A
- Revenue Growth
- CBAN 1.93
- DMAC N/A
- 52 Week Low
- CBAN $10.33
- DMAC $2.14
- 52 Week High
- CBAN $18.49
- DMAC $6.82
- Technical
- Relative Strength Index (RSI)
- CBAN 39.05
- DMAC 45.29
- Support Level
- CBAN $15.55
- DMAC $5.29
- Resistance Level
- CBAN $16.99
- DMAC $5.90
- Average True Range (ATR)
- CBAN 0.37
- DMAC 0.29
- MACD
- CBAN -0.11
- DMAC -0.08
- Stochastic Oscillator
- CBAN 29.66
- DMAC 38.04
About CBAN Colony Bankcorp Inc.
Colony Bankcorp Inc is a bank holding company. The bank provides a broad range of banking services to its retail and commercial customers. Its product line includes loans to small and medium-sized businesses, residential and commercial construction and land development loans, commercial real estate loans, agri-business and production loans, residential mortgage loans, consumer loans, and a variety of demand, savings, and time deposit products. The company's segments include the Banking Division, Retail Mortgage Division, and small business specialty lending divisions. It generates maximum revenue from the Banking Division.
About DMAC DiaMedica Therapeutics Inc.
DiaMedica Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is principally engaged in the business activity of developing treatments for unmet clinical needs or where no therapies are available with a primary focus on chronic kidney disease and acute ischemicstroke. Its pipeline product DM199 is a recombinant form of human tissue kallikrein-1.